×
About 825 results

ALLMedicine™ Strongyloidiasis Center

Research & Reviews  304 results

Evaluation of Strongyloidiasis in Ecuador: a fieLd Laboratory Accuracy Study
https://clinicaltrials.gov/ct2/show/NCT04999774

May 18th, 2022 - Aim and objectives The aim of this project is to provide fundamental information on the performance and applicability of diagnostic methods for the assessment of S. stercoralis infection to inform the forthcoming WHO global strongyloidiasis contro...

Endemic Thoracic Infections in Sub-Saharan Africa.
https://doi.org/10.1016/j.rcl.2022.01.003
Radiologic Clinics of North America; Rydzak CE, Lima AS et. al.

May 10th, 2022 - Although many of the thoracic infections endemic to Africa are also present around the world, this article focuses on entities that are emerging or disproportionately affect populations living in sub-Saharan Africa. Important emerging or reemergin...

Prevalence of Strongyloides stercoralis infection and associated clinical symptoms amon...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049318
PLoS Neglected Tropical Diseases; Jember TH, Amor A et. al.

Apr 29th, 2022 - Strongyloides stercoralis is a parasite that causes strongyloidiasis in humans. It is prevalent in the tropics and sub-tropics where poor sanitation is a common problem. The true prevalence of S. stercoralis in Ethiopia is underestimated due to th...

The accuracy of a recombinant antigen immunochromatographic test for the detection of S...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034504
Parasites & Vectors; Tamarozzi F, Longoni SS et. al.

Apr 25th, 2022 - Strongyloidiasis, a nematode infection which is mainly caused by Strongyloides stercoralis in humans, can lead to a fatal syndrome in immunocompromised individuals. Its diagnosis is challenging due to the absence of a diagnostic gold standard. The...

Prevalence of Chagas disease and strongyloidiasis among HIV-infected Latin American imm...
https://doi.org/10.1016/j.tmaid.2022.102324
Travel Medicine and Infectious Disease; Rodari P, Tamarozzi F et. al.

Apr 4th, 2022 - Screening HIV-positive migrants for neglected tropical diseases having potential for life-threatening reactivation, such as Chagas disease and strongyloidiasis is not widely implemented. We evaluated the prevalence of these infections among a larg...

see more →

Drugs  5 results see all →

Clinicaltrials.gov  6 results

Evaluation of Strongyloidiasis in Ecuador: a fieLd Laboratory Accuracy Study
https://clinicaltrials.gov/ct2/show/NCT04999774

May 18th, 2022 - Aim and objectives The aim of this project is to provide fundamental information on the performance and applicability of diagnostic methods for the assessment of S. stercoralis infection to inform the forthcoming WHO global strongyloidiasis contro...

Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms
https://clinicaltrials.gov/ct2/show/NCT04407507

May 21st, 2021 - In late 2019, an unidentified viral pneumonia was detected in Wuhan, China. Later, it was declared that it was pneumonia due to a new coronavirus. The World Health Organization (WHO) officially called it COVID-19 disease (Xie and Chen 2020). Iverm...

Strongyloides Stercoralis in Bone Marrow Transplant Recipients in the UK
https://clinicaltrials.gov/ct2/show/NCT04709848

Jan 14th, 2021 - Strongyloidiasis is a worm infection which affects more than 100 million people, mostly in Africa, Asia and Latin America. Infection can persist for decades, and usually causes mild symptoms. In some people with reduced immune systems (for example...

Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis
https://clinicaltrials.gov/ct2/show/NCT01570504

Jun 14th, 2018 - Ivermectin is currently the best drug to cure strongyloidiasis, but the "standard" single dose of 200 mcg/kg is probably not enough to guarantee cure. As strongyloidiasis can be fatal in immunosuppressed patients, it is mandatory to define the opt...

Ivermectin Versus Albendazole for Chronic Strongyloidiasis
https://clinicaltrials.gov/ct2/show/NCT00765024

Sep 7th, 2017 - A prospective controlled trial to compare the efficacy and safety of 7-day albendazole, single dose ivermectin, and 2-single dose ivermectin in 72 patients with chronic strongyloidiasis will be conducted at Siriraj Hospital, Bangkok, Thailand.

see more →

News  15 results

Ivermectin and COVID: Is a Microscopic Worm the Key?
https://www.medscape.com/viewarticle/970567

Mar 22nd, 2022 - This transcript has been edited for clarity. Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I'm Dr F. Perry Wilson of the Yale School of Medicine If you took a random sample of 100 people from around the world, ei...

Ivermectin Did Not Reduce COVID Hospitalizations, Study Shows
https://www.medscape.com/viewarticle/970728

Mar 22nd, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The anti-parasitic drug ivermectin does not reduce hospitalizations of people infected with COVID-19, according to a large study conducted in Cana...

FDA Warns Against Using Ivermectin to Treat COVID-19
https://www.medscape.com/viewarticle/947049

Mar 8th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The US Food and Drug Administration (FDA) has issued guidance warning consumers against using the antiparasitic drug ivermectin to treat or preven...

Petechial Rash on the Thighs in an Immunosuppressed Patient
https://www.mdedge.com/dermatology/article/223579/mixed-topics/petechial-rash-thighs-immunosuppressed-patient
Angie Y. Wan, BA, Melissa Piliang, MD

Jun 9th, 2020 - The Diagnosis: Disseminated Strongyloidiasis Strongyloidiasis is a parasitic infection caused by Strongyloides stercoralis. In the United States it is most prevalent in the Appalachian region.

Consider strongyloidiasis before giving oral steroids
https://www.mdedge.com/infectiousdisease/article/137867/infectious-diseases/consider-strongyloidiasis-giving-oral-steroids
Bianca Nogrady

May 9th, 2017 - SYDNEY – Think twice before prescribing oral steroids for patients who have urticarial dermatitis, diarrhea, and cough, especially if they have lived in or recently traveled to tropical areas, Ian McCrossin, MD, said at the annual meeting of the A.

see more →